Thousands of children living with diabetes may soon have a new treatment option that eliminates the need for needles.
RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the ...
Pierre Karl Péladeau, on behalf of Financière Outremont Inc. ("Financière Outremont"), holding nearly 10% of the shares of Transat A.T. Inc. ("Transat" or the "Company"), acknowledges the response ...
The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback